CLOUD-R HAE REGISTRY

Recruiting Observational Study
ANGIOEDEMA
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Sex
Any
Study type
Observational
Participants needed
1,000 (estimated)
Sponsor
University Hospital, Grenoble · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Angioedema is a disease characterized by the appearance of self-limiting edema that last 1-5 days and affect the subcutaneous tissue and/or gastrointestinal and oropharyngeal mucosa. In this last location edema can be lethal causing asphyxia, in all other cases full recovery is complete. Attacks can appear as part of the syndrome urticaria angioedema and can be of allergic origin. But there is a g…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Any patient with isolated angioedema without associated wheals. * Patients with hereditary angioedema with or without C1 deficiency. * Major patient with consent (signature) * Minor patient whose parents / legal guardians have given their consent (signature) Exclusion Criteri…
Contacts

laurence bouilelt, MD, PhD

+33476765565

lbouillet@chu-grenoble.fr

CONTACT

Isabelle Boccon-Gibod

+3347676767640

iboccon-gibod@chu-grenoble.fr

CONTACT